Literature DB >> 7055596

Tissue sites of catabolism of rat and human low density lipoproteins in rats.

R C Pittman, A D Attie, T E Carew, D Steinberg.   

Abstract

We have determined the sites of degradation of low density lipoprotein in rats using covalently linked [14C] sucrose as tracer. On degradation, 14C is trapped intracellularly as a cumulative measure of the amount of protein catabolized by each tissue. [14C] Sucrose-labeled rat low density lipoprotein (d 1.02-1.05 g/ml) was cleared from the plasma at a rate (0.092 +/- 0.003 h-1) similar to that for 125I-labeled LDL (0.096 +/- 0.22 h-1). Tissues were examined for total 14C content 24 h after injection of 14C-labeled lipoprotein. At death, animals were perfused thoroughly to remove trapped plasma. Recovery of 14C in tissue was 100 +/- 23% of catabolized 14C-labeled lipoprotein (calculated from plasma decay kinetics). In three test tissues, leakage of 14C over 5 days was less than 10%/day; leakage from liver was 10%/day, predominantly into bile; 14C content of kidney increased slightly. Thus, 14C trapping was adequate. The 14C-labeled lipoprotein was catabolized 66.8 +/- 2.5% by liver. No other organ catabolized more than 8%. Liver, adrenal and ovary were the most active per unit wet weight, followed by spleen. Urinary excretion, in 24h, was 3% and biliary excretion was 7% of catabolized. Human low density lipoproteins were similarly examined with similar results; this similarity may be due to exchange of rat apolipoproteins onto human lipoprotein in the circulation.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7055596     DOI: 10.1016/0005-2760(82)90183-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  13 in total

1.  Receptor-independent low density lipoprotein transport in the rat in vivo. Quantitation, characterization, and metabolic consequences.

Authors:  D K Spady; S D Turley; J M Dietschy
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

2.  Short- and long-term effects of biliary drainage on hepatic cholesterol metabolism in the rat.

Authors:  M J Smit; A M Temmerman; R Havinga; F Kuipers; R J Vonk
Journal:  Biochem J       Date:  1990-08-01       Impact factor: 3.857

3.  Radioimmunotherapy: no news from the newcomer.

Authors:  A M Mello; E K Pauwels; F J Cleton
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

4.  Quantitative role of parenchymal and non-parenchymal liver cells in the uptake of [14C]sucrose-labelled low-density lipoprotein in vivo.

Authors:  L Harkes; J C Van Berkel
Journal:  Biochem J       Date:  1984-11-15       Impact factor: 3.857

5.  A radioiodinated, intracellularly trapped ligand for determining the sites of plasma protein degradation in vivo.

Authors:  R C Pittman; T E Carew; C K Glass; S R Green; C A Taylor; A D Attie
Journal:  Biochem J       Date:  1983-06-15       Impact factor: 3.857

6.  Uptake of lactosylated low-density lipoprotein by galactose-specific receptors in rat liver.

Authors:  M K Bijsterbosch; T J Van Berkel
Journal:  Biochem J       Date:  1990-08-15       Impact factor: 3.857

7.  Metabolism of low density lipoproteins in rainbow trout.

Authors:  T Gjøen; T Berg
Journal:  Fish Physiol Biochem       Date:  1992-02       Impact factor: 2.794

8.  Uptake of low density lipoproteins by human leukemic cells in vivo: relation to plasma lipoprotein levels and possible relevance for selective chemotherapy.

Authors:  S Vitols; B Angelin; S Ericsson; G Gahrton; G Juliusson; M Masquelier; C Paul; C Peterson; M Rudling; K Söderberg-Reid
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

9.  Cholesterol synthesis and low density lipoprotein uptake are regulated independently in rat small intestinal epithelium.

Authors:  E F Stange; J M Dietschy
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

10.  Uptake of low density lipoproteins by rat tissues. Special emphasis on the luteinized ovary.

Authors:  E Reaven; Y D Chen; M Spicher; S F Hwang; C E Mondon; S Azhar
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.